Pharma

Rubicon Healthcare Partners (RHP), a growth equity asset manager primarily focused on Nordic life science companies, has appointed Claire Knoph as COO and CFO. Her...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction...

France-based Servier, an independent international pharmaceutical group governed by a foundation, is to acquire sevasemten and the muscular dystrophy business of Edgewise Therapeutics, a US-based muscle disease...

Japan-headquartered Meiji Seika Pharma has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC),...

US-based global healthcare and life sciences investor, Ampersand Capital Partners, has  announced the closing of its latest fund, Ampersand 2026, with US$1.5bn in LP commitments....

Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle. The acquisition builds on CordenPharma’s global facility network of 11...

SIX-listed CDMO, Siegfried, has issued a CHF200m four-year bond paying a coupon of 1.35%. “This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility...

Avista Healthcare Partners, a US-based healthcare-focused private equity firm, and Damier Group, the Belgium-based family office of Yvan Vindevogel, have signed a definitive agreement...

A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for...

London-based European specialist healthcare investor, GHO, and CBC Group, an Asian healthcare-focused asset manager, are merging to create the world’s largest dedicated healthcare investment...